Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G et al (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension
Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, et al
Never discontinue GLP-1 medications without medical advice , as abrupt cessation may lead to deteriorating glycaemic control with its own risks
However, the FDA has warned that they do not undergo federal review for safety, effectiveness and quality before they are marketed
You will likely be turned away if you have a history of pancreatitis (pancreas inflammation), a thyroid cancer called medullary thyroid carcinoma in your family, if you are pregnant, if your weight has changed by more than 11 lbs in the past 3 months, or if you are already taking a weight loss drug
Glucagonlike peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation